Bone cancer, in particular, is considered to be one of the most severe and life-changing types of cancer. It grows and can attack the patient at an early and vulnerable stage of life. Chemotherapy, as a form of cancer treatment, has always taken the leading role in the fight against bone cancer. Whether it is osteosarcoma and Ewing's sarcoma, or other life-damaging cancer cells, the procedure offers hope where there was once no hope.
Chemotherapy represents more than a medical treatment, because it is a significant and life-changing experience for the majority. Although the results of chemotherapy are initially promising, this hope and promise are often overshadowed by the uncomfortable fact of “chemotherapy resistance”.
As cancer cells learn how to fight against chemotherapy, the situation becomes more complex and uncertain. It is termed “chemotherapy resistance” clinically. Understand all the critical aspects of chemotherapy resistance in bone cancer treatment to better manage the condition.
What is chemotherapy resistance?
Thinking about any kind of complication or resistance in bone cancer treatment can make patients scared. Chemotherapy resistance is one such phenomenon that can transform hopes into disappointment. Sometimes cancer cells are either completely refractory to chemotherapy from the outset (intrinsic resistance) or gradually become less responsive over time (acquired resistance).
In bone cancers, such as osteosarcoma, this phenomenon of resistance can result in a decrease in the efficacy of commonly used chemotherapeutic agents, such as doxorubicin, cisplatin, and methotrexate.
The exact mechanisms of this phenomenon of resistance are complex. These may include increased drug efflux, enhanced DNA repair, changes in drug targets, and evasion of apoptosis or cell death. Therefore, despite using chemotherapy in adequate doses, these drugs are no longer capable of inducing cell death in cancer cells.
Once resistance occurs, tumors may no longer shrink in size and may even start to grow despite continued treatment. Such a process not only makes management a problem, but it also impacts the efficacy of other available treatment options.
Therefore, resistance to chemotherapy in bone cancers is associated with lower survival rates and increased metastasis, making this a major problem in bone cancer treatment.
Causes of chemotherapy resistance in bone cancer treatment
Chemotherapy resistance is a complex phenomenon. It doesn’t occur for any single reason. Multiple factors contribute to it instead. A complex interplay of biological mechanisms within cancer cells and their surrounding environment is responsible for it. Some of these are:
1. Genetic mutations and tumor heterogeneity
Bone tumors are not homogeneous; rather, they are made up of different populations of cells with various types of genetic mutations. Some of the cells might naturally be resistant to chemotherapy. This means that with time, the chemotherapy kills the vulnerable cells while the resistant ones remain alive.
This is referred to as tumor heterogeneity. Among the reasons for the development of chemotherapy resistance in bone cancer treatment, it is at the top of the list.
2. Drug efflux mechanisms
Cancer cells are naturally strong. This is why heavy treatment like chemotherapy is used to kill them. During the procedure, some cells develop the ability to expel the chemotherapy before the chemotherapy can act on the cells.
This is often through the action of proteins such as P-glycoproteins, which act as “pumps” on the cell membrane.
This means that even when the chemotherapy is taken into the cell, it is pumped out before the desired action occurs. The overall impact of the treatment becomes null and void.
3. DNA Repair Enhancement
The main mechanism of chemotherapy is to attack the DNA of the cancer cells. It eventually kills the cells. The resistant cells develop ways to enhance DNA repair. This means that instead of the chemotherapy killing the cells, the cells are able to repair the DNA damaged by the chemotherapy. The cells then remain alive to continue growing.
4. Tumor microenvironment
Another factor that could influence the development of drug resistance is the tumor microenvironment. It comprises blood vessels, immune cells, and connective tissues.
In the case of bone cancer, the intricate structure of the bone tissue could interfere with the movement of the drug and make it difficult for it to reach the cancer cells. Some of the signals received from the microenvironment could make the cancer cells resistant to the drug.
5. Cancer stem cells
The role of cancer stem cells in the tumor has been considered crucial in drug resistance. These specific cells have the capacity to regenerate the tumor. They have more resistance to the drug than other cancer cells.
Any drug or treatment can completely destroy cancer cells, but stem cells remain alive and regrow the tumor.
Strategies to overcome chemotherapy resistance
As the above discussion shows, chemotherapy resistance in bone cancer treatment could be a strong barrier to patients' survival and cure. This is why finding ways to overcome it is the main focus of researchers and clinicians. Several promising strategies are emerging.
1. Combination therapy
The use of multiple drugs that have different mechanisms of action may reduce the likelihood that cancer cells can develop resistance to the drugs. The procedure is known as combination therapy. The simultaneous effect of multiple drugs kills cancer cells that are resistant to a single medicine.
2. Targeted therapy
Unlike chemotherapy, targeted therapy targets specific molecules that help cancer cells survive and grow. It can avoid some drug resistance mechanisms.
3. Immunotherapy
Immunotherapy utilizes the body's immune system in fighting cancer. It is an alternative approach that does not kill cancerous cells directly. Therefore, it is an effective treatment for cancer even when chemotherapy fails.
4. Inhibitors of drug resistance mechanisms
Scientists have been working on drugs that inhibit drug resistance mechanisms, such as drug efflux and improved DNA repair. The use of these inhibitors helps to restore drug sensitivity when combined with chemotherapy.
5. Personalized medicine
Advancements in genetic testing have enabled doctors to identify particular mutations within a patient's tumor. It allows doctors to select treatments based on individual cases, making them effective and avoiding ineffective drugs.
Get the Most Out of Bone Cancer Treatment
Bone cancer comes with a lot of suffering and challenges. Among these challenges, resistance to chemotherapy is the greatest. It is a state where, for some reason, cancer cells have learned how to defend themselves against the effects of chemotherapy.If you notice persistent bone pain, swelling, or a lump that doesn’t go away, get assessed early by an experienced orthopedic clinic.
Thanks to advancements in science and medicine, doors are opening to more effective ways of solving this problem. As researchers are gaining a deep understanding of the phenomenon, even better treatment strategies are emerging as researchers.
Therefore, statistics show better survival rates. Despite being a serious issue, it is possible to overcome chemotherapy resistance in bone cancer treatment through innovative strategies and, more importantly, the willpower of patients.
